<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2945">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320953</url>
  </required_header>
  <id_info>
    <org_study_id>ncMCE1</org_study_id>
    <nct_id>NCT04320953</nct_id>
  </id_info>
  <brief_title>Non-contact Endoscopy at Covid-19 Outbreak</brief_title>
  <official_title>Non-contact Endoscopy at Covid-19 Outbreak</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COVID-19 outbreak and spread throughout the world now constitutes a global public health
      emergency. Direct contact between doctors and patients in daily practice bears potential risk
      of Covid-19 infection, and telemedicine, or non-contact medicine, in this circumstance,
      offers an ideal solution. Remote controlling capsule endoscopy system for gastric examination
      was recently developed and applicated in clinical practice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The novel non-contact magnetically-controlled capsule endoscopy (MCE) system (Ankon
      Technologies, China) adds a remote control workstation and a audio-visual exchange system to
      the original well-establish MCE system, which consists of a robotic magnetic arm, a
      workstation (now bypassed) and a capsule endoscope, and boasts a 90% sensitivity and 94%
      specificity for diagnosing gastric focal lesions. This feasibility study aims to evaluate the
      technical success, clinical success and adverse events of the first clinical application of
      non-contact MCE system.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 16, 2020</start_date>
  <completion_date type="Actual">April 9, 2020</completion_date>
  <primary_completion_date type="Actual">March 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical success</measure>
    <time_frame>During the procedure</time_frame>
    <description>Maneuvarability of the remote control MCE system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>During the procedure</time_frame>
    <description>Complete observation of the mucosa (&gt;90% of the mucosa observed) in gastric cardia, fundus, body, angulus, antrum and pylorus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>During and within 2 weeks after the procedure</time_frame>
    <description>Adverse events during and after the procedure</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Gastrointestinal Disease</condition>
  <condition>Infectious Disease</condition>
  <arm_group>
    <arm_group_label>Non-contact MCE examination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study subject in this arm receives non-contact MCE examination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-contact MCE system</intervention_name>
    <description>After an overnight fasting and drinking 1000 mL water and simethicone for gastric dilatation and preparation, the study subject positions himself (herself) on the examination bed in Room A, while the operating doctor sits in Room B at the remote control workstation instructing her to swallow the capsule via the audio-visual exchange system. After the capsule entering the stomach, the doctor manipulated the two joysticks on the remote control workstation, mobilizing the robotic magnetic arm, and simultaneously driving the precise movement and rotation of the capsule to perform the gastric examination.</description>
    <arm_group_label>Non-contact MCE examination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed the informed consents before joining this study

        Exclusion Criteria:

          -  Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal
             stenosis, history of upper gastrointestinal surgery or abdominal surgery altering
             gastrointestinal anatomy

          -  Refused abdominal surgery to take out the capsule in case of capsule retention

          -  Implanted pacemaker, except the pacemaker is compatible with MRI

          -  Other implanted electromedical devices or magnetic metal foreign bodies

          -  Pregnancy or suspected pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhuan Liao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changhai Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020 Apr 30;382(18):1679-1681. doi: 10.1056/NEJMp2003539. Epub 2020 Mar 11.</citation>
    <PMID>32160451</PMID>
  </reference>
  <reference>
    <citation>Liao Z, Hou X, Lin-Hu EQ, Sheng JQ, Ge ZZ, Jiang B, Hou XH, Liu JY, Li Z, Huang QY, Zhao XJ, Li N, Gao YJ, Zhang Y, Zhou JQ, Wang XY, Liu J, Xie XP, Yang CM, Liu HL, Sun XT, Zou WB, Li ZS. Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1266-1273.e1. doi: 10.1016/j.cgh.2016.05.013. Epub 2016 May 20.</citation>
    <PMID>27211503</PMID>
  </reference>
  <reference>
    <citation>Zhao AJ, Qian YY, Sun H, Hou X, Pan J, Liu X, Zhou W, Chen YZ, Jiang X, Li ZS, Liao Z. Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals. Gastrointest Endosc. 2018 Sep;88(3):466-474.e1. doi: 10.1016/j.gie.2018.05.003. Epub 2018 May 9.</citation>
    <PMID>29753039</PMID>
  </reference>
  <reference>
    <citation>Tai FWD, Ching HL, Hale MF, McAlindon ME. Upper gastrointestinal endoscopy: can we cut the cord? Lancet Gastroenterol Hepatol. 2019 Oct;4(10):749-751. doi: 10.1016/S2468-1253(19)30262-6.</citation>
    <PMID>31511198</PMID>
  </reference>
  <reference>
    <citation>Jiang X, Qian YY, Liu X, Pan J, Zou WB, Zhou W, Luo YY, Chen YZ, Li ZS, Liao Z. Impact of magnetic steering on gastric transit time of a capsule endoscopy (with video). Gastrointest Endosc. 2018 Oct;88(4):746-754. doi: 10.1016/j.gie.2018.06.031. Epub 2018 Jul 11.</citation>
    <PMID>30005825</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 21, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhuan Liao</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

